Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis
{{output}}
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease with poor prognosis. Although antifibrotic therapies such as pirfenidone and nintedanib slow lung function decline, optimal manag... ...
